Longitudinal studies also show that autoantibodies against 70Kapopare not significantly correlated with disease flares. == Methods == == Patient sera == All individuals were seen in the Department of Rheumatology of the University Medical Centre Nijmegen or the St Maartenskliniek Nijmegen (The Netherlands), and were classified in accordance with standard criteria for each disease. these apoptosis-specific antibodies decrease in time. These findings show that the early detection of apoptotic 70K is definitely of considerable interest for Ro 48-8071 anti-U1 snRNP-positive individuals. Keywords:apoptosis, autoantibodies, combined connective cells disease, U1 snRNP, U1-70K == Intro == Patients suffering from autoimmune diseases are characterized by the presence of autoantibodies directed to a wide range of autoantigens. Mixed connective cells disease (MCTD) is definitely a relatively rare systemic autoimmune disease and includes a group of individuals with overlapping medical symptoms of systemic lupus erythematosus (SLE), systemic sclerosis (SSc), rheumatoid arthritis and polymyositis/dermatomyositis. Sharp and colleagues were the first to describe MCTD as a Rabbit polyclonal to AMACR distinct rheumatic disease [1], but whether MCTD can be regarded as a unique disorder has been a subject of conversation [2]. A characteristic serological feature that distinguishes MCTD individuals from Ro 48-8071 individuals with additional connective cells diseases is definitely high levels of autoantibodies directed against the U1 small nuclear ribonucleoprotein (snRNP) particle [1,3]. The U1 snRNP is definitely a highly conserved RNAprotein complex, located in the nucleus, where it is involved in the processing of pre-mRNA [4,5]. It consists of the U1 snRNA molecule and several proteins: the U1A, U1C and U1-70K (70K) proteins are components specific for the U1 snRNP, whereas the seven Sm proteins (B/B’, D1, D2, D3, E, F and G) are shared with additional U snRNPs [6]. Most U1 snRNP parts are autoantigenic in MCTD and SLE. Autoantibodies directed against U1A, U1C, 70K and the U1 snRNA molecule are primarily found in MCTD individuals, whereas autoantibodies focusing on Sm-D, Sm-B/B’ and the E.F.G complex are more specifically associated with SLE [7,8]. The mechanisms through which such autoantigens, generally highly conserved and ubiquitously indicated molecules, escape tolerance and are identified by the immune system as nonself remain unclear, but it is definitely proposed that cell death is important in the initiation of autoimmune reactions [9,10]. Recently, secondary necrosis has also been put forward like a source of proteolytically altered autoantigens [11], but the modifications that happen on autoantigens during apoptosis were studied most extensively. Apoptotic modifications on autoantigens include specific cleavage by caspases or granzyme B, (hyper)phosphorylation, dephosphorylation, citrullination, methylation and transglutaminase cross-linking [10,12,13], and it is thought that these modifications might be seen by the immune system as novel ‘cryptic’ epitopes. It is believed that these novel epitopes induce the primary immune response, and that secondary immune reactions and epitope distributing result in autoantibodies that are directed against unmodified regions of the autoantigens and antigens that are associated with the in the beginning altered autoantigen [9]. One of the apoptotic modifications occurring within the U1 snRNP is the cleavage of 70K at residue 341 by caspase-3 [14,15]. Antibodies against 70K are in general the Ro 48-8071 first autoantibodies to appear in anti-U1 snRNP (often referred to as anti-RNP) positive individuals, indicating that 70K is important as an initial autoantigen [16]. The molecular and immunological characteristics of the major apoptotic isoform of 70K, a 40 kDa cleavage product that remains associated with the U1 snRNP complex [17], and its part in the triggering of the primary and possibly secondary autoimmune response, are therefore intriguing. Recently it was demonstrated that sera of some anti-U1 snRNP positive individuals contain antibodies that specifically bind to the apoptotic form of 70K, which displays an epitope that is not present within the undamaged form [18,19]. This epitope is dependent on the region between amino acids 180 and 205, partly overlapping with the RNA-binding website and overlapping with the most common T cell epitope [20]. With this study we analyzed a cohort of MCTD and control individuals for the presence of autoantibodies against undamaged and apoptotic 70K. Moreover, we longitudinally analyzed sera from another group of MCTD individuals. Our results display that, early in disease, autoantibodies directed against the apoptotic form of 70K (70Kapop) are more strongly represented.